<DOC>
	<DOCNO>NCT01143766</DOCNO>
	<brief_summary>The standard approach sedation endoscopic retrograde cholangiopancreatography ( ERCP ) involve use benzodiazepine opiate achieve moderate depth sedation . There data suggest supplement regimen gabapentin may lead reduce pain , high patient satisfaction lower opiate requirement . The investigator conduct clinical trial study hypothesis .</brief_summary>
	<brief_title>Gabapentin Improve Patient Tolerance Endoscopic Retrograde Cholangiopancreatography ( ERCP )</brief_title>
	<detailed_description />
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Male female patient &gt; 18 year age refer IUMC firsttime ERCP procedure . 1 . Pregnant woman 2. age &lt; 18 year 3 . Incarcerated individual 4 . Patients currently take take gabapentin pregabalin within last 3 month 5 . Patients unable give inform consent 6 . Patients able fill visual analog scale pain , nausea anxiety unable fill survey regard procedural satisfaction . 7 . High risk patient anesthesia : home oxygen , class III IV heart failure , sleep apnea ( CPAP/BiPAP home ) , ASA class &gt; 3 . 8 . Patients undergo general anesthesia ERCP procedure 9 . Patients receive propofol sedation ERCP procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Sedation</keyword>
	<keyword>Gabapentin</keyword>
	<keyword>ERCP</keyword>
	<keyword>Endoscopy</keyword>
</DOC>